PepGen Investors Encouraged to Act Before Deadline
Bragar Eagel & Squire, P.C., litigation attorneys, are actively reaching out to investors who have suffered losses due to the recent developments involving PepGen (PEPG). They encourage those impacted to contact their firm to discuss potential legal actions and options available to them.
Understanding the Class Period and Legal Rights
Investors who purchased or acquired securities in PepGen during the specified period are urged to take notice. The class period extends from March 7, 2024, to March 3, 2025. During this time, individuals and entities may have a claim due to alleged misleading statements made by the company.
Important Actions for Investors
Those who believe they have incurred losses during this period should consider acting promptly. Contacting Bragar Eagel & Squire can provide clarity on your situation and any potential legal avenues. Bran Walker and Marion Passmore are available to discuss these matters directly.
Recent Legal Developments
A class action lawsuit has recently been filed against PepGen in the United States District Court for the Eastern District. This legal action represents all investors who purchased PepGen securities within the defined class period. The deadline to apply for lead plaintiff status in this lawsuit is August 8, 2025.
Allegations Against PepGen
The complaint asserts that during the class period, PepGen made several materially false and misleading statements regarding its business operations and future prospects. Specifically, it suggests that the efficacy and safety of PGN-EDO51, a key product, were misrepresented, creating an inflated perception of PepGen's performance and potential.
Potential Outcomes and Next Steps
If you are a long-term stockholder or believe you have information pertinent to these claims, you should connect with legal professionals immediately. They can guide you through the next steps and inform you about your legal rights regarding these allegations against PepGen. Open channels of communication will allow for a collaborative approach to these serious concerns.
About Bragar Eagel & Squire, P.C.
This law firm has established a reputation for serving individual and institutional investors in complex legal matters. Their dedicated team represents clients in significant litigation across various courts within the United States. Their experience equips investors with the knowledge necessary in navigating such challenging legal circumstances.
Contact Information for Concerns
For those wishing to have a conversation about their rights regarding PepGen's recent actions, contacting Bragar Eagel & Squire, P.C. is advisable. Their office is equipped to handle inquiries and assist clients in seeking justice and reclamation of any potential losses incurred.
Frequently Asked Questions
1. What is the deadline for investors regarding the PepGen lawsuit?
The deadline for investors to apply for lead plaintiff status in the PepGen class action lawsuit is August 8, 2025.
2. How can I find out if I qualify for the lawsuit?
If you purchased PepGen securities during the class period, consulting with Bragar Eagel & Squire about your legal options is recommended.
3. What are the main allegations against PepGen?
PepGen is accused of making false and misleading statements about the efficacy and safety of its product PGN-EDO51, among other claims.
4. Who can I contact for more information?
Brandon Walker and Marion Passmore at Bragar Eagel & Squire can be contacted directly for inquiries regarding the PepGen situation.
5. What happens if I wait beyond the deadline?
Waiting beyond the deadline may forfeit your opportunity to participate in the lawsuit or recover potential losses. It is crucial to act promptly.
